Device Trial Radar · NCT07636161
PLEASURE (Pleasing Lovers, Efficacy, Arousal, Satisfaction, and Uptake Research on Eroxon)
Last checked: Nov 19, 2026Latest source record: Sep 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Suspended
Enrollment
30
Planned (sponsor's estimate)
Start
Oct 2026
Primary completion
Sep 2027
Study completion Sep 2027
Sponsor
- Lead sponsor
- University of MiamiAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Sexual Medicine Society of North America Inc.
- First posted
- Jun 9, 2026
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- Male only, from 18 years, up to 40 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this research study is to look at whether Eroxon® gel when used together with tadalafil, may help improve erectile function in men ages 18 to 40 who have type 2 diabetes.
Conditions
- Type 2 Diabetes
- Type 2 Diabetes (T2DM)
Interventions
Eroxon®Device
Participants will receive a 12-week supply of Eroxon® and will be instructed to apply the gel prior to each sexual encounter as directed at enrollment.
tadalafilDrug
Tadalafil is administered as standard of care at dose and schedule determined by the treating clinician.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in Erectile FunctioningTime frame: Baseline to Week 12
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Don Soffer Clinical Research Building
Miami, Florida
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.